The incidence of hepatitis C virus in patients with lung cancer

G. Balci, S. Dereli, N. Kurtul, R. Ozacar (Izmir, Turkey)

Source: Annual Congress 2006 - Epidemiology, rare tumors (2), miscellaneous
Session: Epidemiology, rare tumors (2), miscellaneous
Session type: E-Posters in free access
Number: 632
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Balci, S. Dereli, N. Kurtul, R. Ozacar (Izmir, Turkey). The incidence of hepatitis C virus in patients with lung cancer. Eur Respir J 2006; 28: Suppl. 50, 632

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of hepatitis c virus infection among patients with COPD
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


Interstitial lung involvement in patients with chronic HCV hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006

The prevalence rate of chronic hepatitis B and C among pulmonary TB patients
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008

Epstein-barr virus - associated lung cancer study
Source: Eur Respir J 2001; 18: Suppl. 33, 232s
Year: 2001

Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

The frequency of cytomegalovirus infection detecting of patients with lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 153s
Year: 2006

Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019

The prevalence and clinicopathologic feature of human papillomavirus infection in lung cancer patients
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010

Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Incidence of viral infections in patients with lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 87s
Year: 2006

Sarcoidosis associated with interferon-α therapy for chronic hepatitis C
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006

LATE-BREAKING ABSTRACT: Seroprevalence of human herpesvirus type 8 infection in patients with lung carcinoma
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Lung disease associated with the human immunodeficiency virus in Brazilian children
Source: Eur Respir J 2004; 24: Suppl. 48, 717s
Year: 2004

The clinical flow and efficiency of treatment of pulmonary tuberculosis in patients with chorine organic pasticides and viral hepatitis ‘B‘ markers
Source: Eur Respir J 2004; 24: Suppl. 48, 50s
Year: 2004

Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019